Company: PBH
Filing Date: 2025-02-06
Form Type: 10-Q
Source: 0001295947-25-000009
Chunk: 0

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-02-06
Form: 10-Q
Item: Item 3
Chunk 0
---
ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk

Our 2012 ABL Revolver is variable rate debt.  At December 31, 2024 the 2012 ABL Revolver had a zero balance and therefore none of our debt carried a variable rate of interest at December 31, 2024.  

Foreign Currency Exchange Rate Risk 

During the three and nine months ended December 31, 2024, approximately 18.2% and 15.8%, respectively, of our gross revenues were denominated in currencies other than the U.S. Dollar. During the three and nine months ended December 31, 2023, approximately 17.0% and 14.1%, respectively, of our gross revenues were denominated in currencies other than the U.S. Dollar. As such, we are exposed to transactions that are sensitive to foreign currency exchange rates.  These transactions are primarily with respect to the Canadian and Australian Dollars.  

We performed a sensitivity analysis with respect to exchange rates for the three and nine months ended December 31, 2024 and 2023.  Holding all other variables constant, and assuming a hypothetical 10.0% adverse change in foreign currency exchange rates, this analysis resulted in a less than 5.0% impact on pre-tax income of approximately $3.9 million for the three months ended December 31, 2024 and approximately $8.0 million for the nine months ended December 31, 2024.  It represented a less than 5.0% impact on pre-tax income of approximately $2.7 million for the three months ended December 31, 2023 and $6.8 million for the nine months ended December 31, 2023.